EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 2587-2595

  Shire, Kathy ^a   Ceccarelli, Derek F J ^b   Avolio Hunter, Tina M ^a   Frappier, Lori ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CELL NUCLEUS ANTIGEN; PROTEIN;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CHROMOSOME MAP; DELETION MUTANT; EPISOME; EPSTEIN BARR VIRUS; IMMUNOPRECIPITATION; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN ISOLATION;

EID: 0033053194     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.2587-2595.1999     Document Type: Article

References (61)

1. Adams, A. 1987. Replication of latent Epstein-Barr virus genomes. J. Virol. 61:1743-1746.
2. Ambinder, R. F., M. Mullen, Y. Chang, G. S. Hayward, and S. D. Hayward. 1991. Functional domains of Epstein-Barr nuclear antigen EBNA-1. J. Virol. 65:1466-1478.
3. Ausubel, F. M., K. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1991. Current protocols in molecular biology, vol. 1. John Wiley and Sons, New York, N.Y.
4. Avolio-Hunter, T. M., and L. Frappier. 1998 Mechanistic studies on the DNA linking activity of the Epstein-Barr nuclear antigen 1. Nucleic Acids Res. 26:4462-4470.
5. + T cell responses to EBV EBNA1: HLA class I presentation of the (GLY-ALA) containing protein requires exogenous processing. Immunity 7:791-802.
6. Bochkarev, A., J. Barwell, R. Pfuetzner, E. Bochkareva, L. Frappier, and A. M. Edwards. 1996. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin binding protein, EBNA1, bound to DNA. Cell 84:791-800.
7. Bochkarev, A., J. Barwell, R. Pfuetzner, W. Furey, A. Edwards, and L. Frappier. 1995. Crystal structure of the DNA binding domain of the Epstein-Barr virus origin binding protein EBNA1. Cell 83:39-46.
8. Brandl, C. J., A. M. Furlanetto, J. A. Martens, and K. S. Hamilton. 1993. Characterization of NGG1, a novel yeast gene required for glucose repression of GAL4p-regulated transcription. EMBO J. 12:5255-5265.
9. Breeden, L., and K. Naysmith. 1985. Regulation of the yeast HO gene. Cold Spring Harbor Symp. Quant. Biol. 50:643-650.
10. r 40,000 nucleolar antigen associated with cell proliferation. Cancer Res. 47:1123-1129.
11. Chen, M.-R., J. M. Middeldorp, and S. D. Hayward. 1993. Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67:4875-4885.
12. Chen, M.-R., J. Zong, and S. D. Hayward. 1994. Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein. Virology 205:486-495.
13. Chen, W., and K. Struhl. 1988. Saturation mutagenesis of a yeast his3 "TATA clement": genetic evidence for a specific TATA-binding protein. Proc. Natl. Acad. Sci. USA 85:2691-2695.
14. Chittenden, T., S. Lupton, and A. J. Levine. 1989. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication. J. Virol. 63:3016-3025.
15. Delecluse, H.-J., S. Bartnizke, W. Hammerschmidt, J. Bullerdiek, and G. W. Bornkamm. 1993. Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt's lymphoma cell lines. J. Virol. 67:1292-1299.
16. Durfee, T., K. Becherer, P.-L. Chen, S.-H. Yeh, Y. Yang, A. E. Kilburn, W.-H. Lee, and S. J. Elledge. 1993. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555-569.
17. Dworet, J. H., M. Huber, K. Shire, L. Frappier, and M. A. McAlear. The budding yeast homolog of the human EBNA1-binding protein 2 (Ebp2p) is an essential nucleolar protein required for rRNA synthesis and ribosome assembly. Submitted for publication.
18. Fischer, N., E. Kremmer, G. Lautscham, N. Mueller-Lantzsch, and F. A. Grasser. 1997. Epstein-Barr virus nuclear antigen 1 forms a complex with the nuclear transporter karyopherin α2. J. Biol. Chem. 272:3999-4005.
19. Frappier, L., K. Goldsmith, and L. Bendell. 1994. Stabilization of the EBNAI protein on the Epstein-Barr virus latent origin of DNA replication by a DNA looping mechanism. J. Biol. Chem. 269:1057-1062.
20. Frappier, L., and M. O'Donnell. 1991. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 88:10875-10879.
21. Frappier, L., and M. O'Donnell. 1991. Overproduction, purification and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. J. Biol. Chem. 266:7819-7826.
22. Gahn, T., and B. Sugden. 1995. An EBNA1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69:2633-2636.
23. Gahn, T. A., and C. L. Schildkraut. 1989. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 58:527-535.
24. Goldsmith, K., L. Bendell, and L. Frappier. 1993. Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 67:3418-3426.
25. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 5:456-467.
26. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interaction protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
27. Harris, A., B. D. Young, and B. E. Griffin. 1985. Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines. J. Virol. 56:328-332.
28. Harrison, S., K. Fisenne, and J. Hearing. 1994. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 68:1913-1925.
29. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell culture. J. Mol. Biol. 26:365-369.
30. Kieff, E., and D. Liebowitz. 1990. Epstein-Barr virus and its replication, p. 1889-1920. In B. N. Fields and D. M. Knipe (ed.), Virology, 2nd ed. Raven Press, Ltd., New York, N.Y.
31. Kim, A. L., M. Maher, J. B. Hayman, J. Ozer, D. Zerby, J. L. Yates, and P. M. Lieberman. 1997. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin α. Virology 239:340-351.
32. Kirchmaier, A. L., and B. Sugden. 1997. Dominant-negative inhibitors of EBNA1 of Epstein-Barr virus. J. Virol. 71:1766-1775.
33. Klein, G. 1989. Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 58:5-8.
34. Kozak, M. 1991. An analysis of vertebrate mRNA sequencese: intimations of translational control. J. Cell Biol. 115:887-903.
35. Krainer, A. R., G. C. Conway, and D. Kozak. 1990. Purification and characterization of pre-mRNA slicing factor SF2 from HeLa cells. Genes Dev. 4:1158-1171.
36. Lai, J.-S., and W. Herr. 1992. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc. Natl. Acad. Sci. USA 89:6958-6962.
37. Laine, A., and L. Frappier. 1995. Identificalion of Epstein-Barr nuclear antigen 1 protein domains that direct interactions at a distance between DNA-bound proteins. J. Biol. Chem. 270:30914-30918.
38. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
39. Li, L., S. J. Elledge, C. A. Peterson, E. S. Bales, and R. J. Legerski. 1994. Specific association between the human DNA repair proteins XPA and ERCC1. Proc. Natl. Acad. Sci. USA 91:5012-5016.
40. Lupton, S., and A. J. Levine. 1985. Mapping of genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol. 5:2533-2542.
41. Mackey, D., T. Middleton, and B. Sugden. 1995. Multiple regions within EBNA1 can link DNAs. J. Virol. 69:6199-6208.
42. Middleton, T., T. A. Gahn, J. M. Martin, and B. Sugden. 1991. Immortalizing genes of Epstein-Barr virus. Adv. Virus Res. 40:19-55.
43. Miller, G. 1990. Epstein-Barr virus, p. 1921-1958. In B. N. Fields (ed.). Virology, 2nd ed. Raven Press, New York, N.Y.
44. Niller, H. H., G. Glaser, R. Knuchel, and H. Wolf. 1995. Nucleoprotein complexes and DNA 5′-ends at oriP of Epstein-Barr virus. J. Biol. Chem. 270:12864-12868.
45. Petti, L., C. Sample, and E. Kieff. 1990. Subnuclear localization and phosphorylation or Epstein-Barr virus latent infection nuclear proteins. Virology 176:563-574.
46. Polvino-Bodnar, M., and P. A. Schaffer. 1992. DNA binding activity is required for EBNA1-dependent transcriptional activation and DNA replication. Virology 187:591-603.
47. Rawlins, D. R., G. Milman, S. D. Hayward, and G. S. Hayward. 1985. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA1) to clustered sites in the plasmid maintenance region. Cell 42:859-868.
48. Reisman, D., and B. Sugden. 1986. trans Activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6:3838-3846.
49. Reisman, D., J. Yates, and B. Sugden. 1985. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5:1822-1832.
50. Simpson, K., A. McGuigan, and C. Huxley. 1996. Stable episomal maintenance of yeast artificial chromosomes in human cells. Mol. Cell. Biol. 16: 5117-5126.
51. Su, W., T. Middleton, B. Sugden, and H. Echols. 1991. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc. Natl. Acad. Sci. USA 88:10870-10874.
52. Summers, H., J. A. Barwell, R. A. Pfuetzner, A. M. Edwards, and L. Frappier. 1996. Cooperative assembly of EBNA1 on the Epstein-Barr virus latent origin of replication. J. Virol. 70:1228-1231.
53. Wang, Y., J. E. Finan, J. M. Middeldorp, and S. D. Hayward. 1997. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology 236:18-29.
54. Webb, N. R., and M. D. Summers. 1990. Expression of proteins using recombinant baculoviruses. Technique 2:173-188.
55. Wilson, J. B., J. L. Bell, and A. J. Levine. 1996. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15:3117-3126.
56. Wysokenski, D. A., and J. L. Yates. 1989. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol. 63:2657-2666.
57. Yates, J. L., and S. M. Camiolo. 1988. Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells 6:197-205.
58. Yates, J. L., and N. Guan. 1991. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65:483-488.
59. Yates, J. L., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
60. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815.
61. Zhang, D., L. Frappier, E. Gibbs, J. Hurwitz, and M. O'Donnell. 1998. Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus. Nucleic Acids Res. 26:631-637.